RARE CASE, UNIQUE THERAPY: HOW MARGINAL ZONE LYMPHOMA WAS DEFEATED
Specialists of the High-Dose Therapy Department of the P. Hertsen Moscow Oncology Research Institute (MORI) – branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, regularly treat patients with various forms of non-Hodgkin's lymphoma. This time they had to deal with a clinically atypical and relatively rare variant of the disease -...












